Scancell is proposing to raise up to £15m through a combination of shares and convertible loan notes. The raise is underpinned by an investment of £10m (£5m shares and £5m convertible) by Redmile Group LLC, a US based specialist healthcare and life sciences investment fund. Vulpes, the existing major investor, will subscribe £2m (£1m equity and £1m convertible).
11 Aug 2020
Material fund raise means clinical progress in sight 22 July 2020
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Material fund raise means clinical progress in sight 22 July 2020
Scancell Holdings Plc (SCLP:LON) | 10.2 0 0.0% | Mkt Cap: 95.1m
- Published:
11 Aug 2020 -
Author:
Lala Gregorek -
Pages:
2
Scancell is proposing to raise up to £15m through a combination of shares and convertible loan notes. The raise is underpinned by an investment of £10m (£5m shares and £5m convertible) by Redmile Group LLC, a US based specialist healthcare and life sciences investment fund. Vulpes, the existing major investor, will subscribe £2m (£1m equity and £1m convertible).